Cerenion accepted as the only Finnish entrant into the trans-Atlantic MedTech Bridge program

Cerenion is excited to announce it has been selected to take part in a new two-way program between the Nordics and the USA facilitating the expansion from one medical device market to the other.
The MedTech Bridge program is a non-profit initiative run by the Technical University of Denmark (DTU) and funded by a three-year philanthropic grant totaling $1.3 million from the Danish Industry Foundation. The initiative establishes a bridgehead in the USA via the Medical Alley cluster in Minnesota and fosters the building of a trans-Atlantic community and expedited entryway for Nordic medical device companies looking to enter the US market.
"MedTech Bridge has a simple mission: Shorten the distance between local MedTech innovation and the US market", says Tim Damgaard Christensen, Program Director.
"This new program provides Cerenion with an exciting bridge across the big pond, and a community for solving many common questions regarding, for example, regulatory compliance and business development", continues Dr. Ilkka Juuso, COO and co-founder of Cerenion.
Cerenion, who is currently expecting to receive regulatory approval for its C-Trend® brain monitoring technology in Europe, is actively planning for its entry into the US market.
"We feel both grateful and bolstered by this show of Nordic comradery in welcoming us into the bridge program", remarks Dr. Jukka Kortelainen, CEO and co-founder of Cerenion. "We look forward to the program as a medium for learning and doing, and also sharing our experiences with our peers", he continues.
Cerenion gratefully acknowledges the support of Health Capital Helsinki and OuluHealth, as well as the European Regional Development Fund of the European Union and the Centre for Economic Development, Transport and the Environment in North Ostrobothnia in seeking the appropriate regulatory approvals and bringing the Cerenion C-Trend® index to the international market.
MedTech Bridge is established in close collaboration between Danish and US partners. The program became a reality in 2018, thanks to a grant from the Danish Industry Foundation. With two hubs in Denmark and US, Medtech Bridge is perfectly positioned to enable a fast track connection to the #1 health tech cluster in the world, Medical Alley in Minnesota. https://www.medtechbridge.org
Health Capital Helsinki is building the greatest health capital: we boost collaboration within the Greater Helsinki health ecosystem, enable innovation-driven companies to grow and attract foreign companies to establish their businesses. The alliance supporting Health Capital Helsinki consists of main cities, hospital and educational institutions in Finland: Cities of Helsinki and Espoo, HUS Helsinki University Hospital, University of Helsinki, Aalto University, and Helsinki Metropolitan Universities of Applied Sciences Haaga-Helia, Laurea and Metropolia.
OuluHealth is an innovation ecosystem creating solutions for future healthcare. The principal idea is to facilitate open collaboration and to accelerate innovation by bringing together various partners able to contribute to the needs of the health care sector. OuluHealth comprises several stakeholders from academia, public sector and private sector, including the expertise from wireless and smart ICT solutions, enabling the development of advanced, personalized and connected health care solutions.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy